A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer

Background: Cancer patients often display dysfunctional antitumor T-cell responses. Because noteworthy benefits of immune checkpoint pathway blockade, such as programmed cell death protein 1 (PD-1) inhibitors, have been achieved in multiple advanced cancers, the next critical question is which mono-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xi, Wang, Rouzheng, Fan, Peiwen, Yao, Xuan, Qin, Ling, Peng, Yanchun, Ma, Miaomiao, Asley, Neil, Chang, Xuimei, Feng, Yaning, Hu, Yunhui, Zhang, Yonghong, Li, Chris, Fanning, Gregory, Jones, Stephanie, Verrill, Clare, Maldonado-Perez, David, Sopp, Paul, Waugh, Craig, Taylor, Stephen, Mcgowan, Simon, Cerundolo, Vincenzo, Conlon, Christopher, McMichael, Andrew, Lu, Shichun, Wang, Xiyan, Li, Ning, Dong, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823747/
https://www.ncbi.nlm.nih.gov/pubmed/31709176
http://dx.doi.org/10.3389/fonc.2019.01066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823747/
https://www.ncbi.nlm.nih.gov/pubmed/31709176
http://dx.doi.org/10.3389/fonc.2019.01066

Ejemplares similares